Expression evaluation of cell cycle regulatory genes (P27, P21, P14) in AML patient

سال انتشار: 1396
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 444

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ACPLMED19_075

تاریخ نمایه سازی: 20 آبان 1397

چکیده مقاله:

INTRODUCTION: Cell cycle control has a critical role in normal hematopoesis, leukomogenesis can affect key cell cycle regulators such as CDI gene family.P27, P21 and P14 in CKI family are frequently involved in AML. Their defects disrupt the balance between proliferation and apoptosis which can be led to cancer formation. OBJECTIVES: The present study aimed at expression investigation of such essential cell cycle proteins (p21, p27, p14) in bone marrow biopsies and peripheral blood obtained from newly diagnosed acute myeloid leukemia patients. METHODS: The results of present study obtained from bone marrow and peripheral blood sample of 93 newly diagnosed AML patients (39 males and 54 female classified in 3 age group; 35> , 35-60 and > 60 years old) obtained from Taleghani hospital. We have 45 APL patient and 48 Non M3 patient. In addition expression of target genes was detected compared with ABL as housekeeping gene using the ΔΔCT method. RESULTS: P21 and P27 had 1.44 and 4.10 higher expression respectively in comparison with normal control group (PV> 0.05), and average expression fold change of p14 compared with the control group was 3.69 that shown significantreduction (Pv ثƒ0.05). We found no correlation between expression level of the mentioned genes and common AML prognostic factors including: age, gender, blast cell type and even sample type. CONCLUSION: We hypothesized that at the first step they get rid from their anti tumor function and at the second step the malignant cells employ these proteins at their service.

کلیدواژه ها:

نویسندگان

naser shagerdi esmaeli

Department of Hematology, Shahid Beheshti University, Tehran, Iran

mehdi allahbakhshian

Department of Hematology, Shahid Beheshti University, Tehran, Iran

mohammadhossein mohammadi

Department of Hematology, Shahid Beheshti University, Tehran, Iran

Mohieddin Barzegar

Department of Hematology, Shahid Beheshti University, Tehran, Iran